Watch Ticker

CureVac N.V. Ordinary Shares

Go to CureVac N.V. Ordinary Shares Website

$5.46

0.05 (0.92%)

Live

Previous Close

$5.41

Day Range

$5.4 - $5.47

Previous Day Range

$5.36 - $5.42

Market Cap

$1.2 billion USD

Day Vol.

561242

Previous Day Vol.

517156

Currency

USD

Primary Exchange

Nasdaq

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboratio...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech reported Q2 sales of $295.7 million, exceeding expectations, with a narrowed per-share loss. The company strengthened its oncology strategy through a collaboration with Bristol Myers Squibb and plans to acquire CureVac.

Related tickers: BNTX, BMY, CELGr, CVAC, PFE.

Read Full Article

Researchandmarkets.Com - Flu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges

The global flu RNA vaccines market is expected to grow from $2.78 billion in 2025 to $5.95 billion by 2032, driven by advancements in mRNA technology and the need for rapid adaptation to evolving flu strains. North America leads the market, with notable growth in Europe and Asia-Pacific.

Related tickers: MRNA, PFE, BNTX, CVAC, SNY, GSK, ARCT.

Read Full Article

Trending Tickers

Please sign in to view